Pricing Log in Create free account
Friday 6 November 2026 Export AVNT’s income statement to Excel — free account

Avient Corporation

AVNT Basic Materials Specialty Chemicals

Avient Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 0.61% from fiscal 2024.

Revenue
+10.5%
EPS
+31.8%
Free cash flow
+101.7%
Total debt
−7.34%

Quarter to September 2026, against a year earlier

45.65 2.21 −4.62%
Market cap
$4.2B
P/E
23.1×
Fwd P/E
17.6×
Dividend yield
2.41%
F-score
5/9
Altman Z
1.67
Beneish M
−2.54
Dividend safety
36/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 0.92%

Capital & Financial Ratios $m

Size
Market Cap 4,160.00
Revenue ttm 3,416.20
Net income ttm 182.20
Free cash flow ttm 239.00
Net debt Q 1,381.50
Valuation
P/E 23.12
Forward P/E 17.60
Price / sales 1.23
Forward P/S Powerpack
Price / FCF 17.52
Price / book 301.16 (above 6: high)
Financial health
Current ratio Q 1.71 (at or above 1.5: strong)
Debt / equity Q 0.74
Interest coverage Q 3.64
Growth
Revenue growth Q +10.50% (above 0%: growing)
Operating income growth Q +23.10% (above 0%: growing)
EPS, this year +15.48% (at or above 15%: strong)
EPS, next year A +11.57%
Revenue, next year A −25.00% (below 0%: weak)
EPS, past 5 yrs −9.30% (below 0%: weak)
EPS, next 5 yrs A +12.27%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.6×, against a ten-year median of 1.5×; over the ten years it ranged from 0.6× in 2020 to 2.3× in 2021.
P/E against its own 10 years 73.21%
10-year low 10-year high
P/S against its own 10 years 69.49%
10-year low 10-year high
P/B against its own 10 years 74.40%
10-year low 10-year high
EV/Sales against its own 10 years 63.33%
10-year low 10-year high
EV/FCF against its own 10 years 28.90%
10-year low 10-year high

Dividends

Yield
2.41%
Annual rate
1.10
Payout ratio
56.1%
Growth, 2018–26
+1.72%/yr
  1. 0.72 ’18
  2. 0.79 ’19 +9
  3. 0.82 ’20 +4
  4. 0.88 ’21 +7
  5. 0.96 ’22 +10
  6. 1.00 ’23 +4
  7. 1.04 ’24 +4
  8. 1.09 ’25 +4
  9. 0.83 ’26 −24
paid change on the year, % Powerpack

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 546 545 511 446
Receivables 400 400 435 521
Inventory 347 347 367 442
Other 115 131 88 101
1,408 1,422 1,401 1,509
2023 2024 2025 Q'26
Payables 432 417 410 440
ST’ Debt 10 8 1 0
Other — — — —
774 756 846 881

Compound Annual Growth %

10y 5y 3y
Sales 1.08% 8.04% (1.36%)
Cash Flow 2.30% 6.36% (8.86%)
Earnings (5.53%) (9.05%) (51.16%)
Book Value 12.96% 6.87% 0.47%

Earnings Trends EPS, adjusted, against the consensus

Q3 FY26 Estimate 0.81 Actual 0.86

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q4 FY25 0.55 0.56 Beat by 0.01
Q1 FY26 0.81 0.83 Beat by 0.02
Q2 FY26 0.89 0.96 Beat by 0.07
Q3 FY26 0.81 0.86 Beat by 0.05
Q4 FY26 0.61 — Reports 11 February 2027

EPS $

Mar Jun Sep Dec Year
’26 0.61 0.70 0.47 — —
’25 (0.22) 0.57 0.36 0.18 0.89
’24 0.54 0.36 0.41 0.52 1.84
’23 0.22 0.24 0.06 0.31 0.83
’22 0.91 0.92 (0.11) 5.98 7.63
’21 0.86 0.74 0.57 0.32 2.51
’20 0.38 0.25 0.02 0.81 1.45
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 847 917 891 — —
’25 827 867 807 761 3,260
’24 829 850 815 747 3,240
’23 846 824 754 719 3,143
’22 892 891 823 790 3,397
’21 1,162 1,235 818 100 3,316
’20 712 609 925 (30) 2,215
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (34) 94 121 — —
’25 (51) 113 72 168 302
’24 (43) 106 71 123 257
’23 (22) (2) 72 155 202
’22 19 88 117 175 398
’21 4 65 42 124 234
’20 (13) 89 (7) 153 222
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (53) 72 96 — —
’25 (64) 86 47 125 195
’24 (65) 73 50 78 135
’23 (42) (28) 43 110 82
’22 6 67 96 124 293
’21 (13) 39 21 86 133
’20 (24) 79 (25) 128 158
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.7
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 2,939 2,590 2,881 2,863 2,215 3,316 3,397 3,143 3,240 3,260 3,416 +1.2% 2,445 2,518 2,631 (6.9%)
Gross margin, % 23.02 23.02 21.69 22.96 29.80 28.47 25.99 28.40 32.61 31.15 31.66 +8.1 pt
EBT 227 112 102 109 61 204 64 87 225 112 244 (7.6%)
EBT margin, % 7.71 4.32 3.53 3.82 2.76 6.14 1.88 2.78 6.94 3.43 7.15 (4.3) pt
Net income 165 (58) 160 589 133 231 703 76 171 84 182 (7.3%)
Per share, $
Per share, $ Revenue 35.03 31.78 36.15 37.08 24.58 36.27 37.25 34.50 35.49 35.63 37.25 +0.2%
Earnings 1.97 (0.71) 2.01 7.62 1.46 2.53 7.71 0.83 1.86 0.90 1.97 (8.3%)
Cash flow 2.71 2.48 3.18 3.90 2.46 2.56 4.37 2.21 2.81 3.30 3.79 +2.2%
Capex (1.00) (0.98) (0.90) (1.06) (0.71) (1.10) (1.16) (1.31) (1.34) (1.16) (1.19) +1.7%
Free cash flow 1.71 1.51 2.28 2.84 1.75 1.46 3.21 0.90 1.48 2.13 2.61 +2.5%
Book value 8.65 7.35 6.78 13.64 19.00 19.59 25.80 25.66 25.52 26.08 26.94 +13.0%
Shares, m 84 82 80 77 90 91 91 91 91 92 92 +1.0%
Valuation, ×
Valuation, × P/E 16.55 0.00 14.30 4.82 27.59 22.11 4.40 49.54 21.97 35.10 23.12 19.6
P/S 0.93 1.39 0.79 0.99 1.64 1.54 0.91 1.19 1.15 0.88 1.23 1.1
P/B 3.75 6.00 4.22 2.70 2.12 2.86 1.32 1.60 1.60 1.20 301.16 2.7
EV/Sales 1.28 1.80 1.20 1.12 2.19 1.92 1.36 1.68 1.62 1.31 1.63 1.5
EV/FCF 26.17 37.96 19.03 14.63 30.73 47.83 15.83 64.24 38.94 21.90 23.30 31.7
Cash, $m
Cash, $m Operating cash flow 228 202 254 301 222 234 398 202 257 302 348 +3.2%
Capex (84) (80) (72) (82) (64) (101) (105) (119) (122) (107) (109) +2.7%
Free cash flow 143 123 182 219 158 133 293 82 135 195 239 +3.5%
Balance, $m
Balance, $m Working capital 440 496 441 811 801 886 700 634 666 555 629 +2.6%
Net debt 1,032 1,065 1,185 365 1,223 1,258 1,538 1,534 1,523 1,413 1,382 +3.5%
Shareholders’ equity 726 599 541 1,053 1,712 1,791 2,353 2,338 2,330 2,386 2,471 +14.1%
Returns, %
Returns, % ROA 6.20 (2.12) 5.89 19.63 3.23 4.68 12.69 1.26 2.88 1.38 3.00 (4.8) pt
ROIC 9.52 6.50 6.47 6.91 2.38 5.73 3.91 3.18 5.34 3.35 5.36 (6.2) pt
ROE 23.09 (8.71) 28.04 73.88 9.52 13.18 33.94 3.23 7.26 3.47 14.99 (19.6) pt
People
People Employees 7,000 6,300 6,600 5,600 8,400 8,700 9,700 9,300 9,200 9,000 — +2.8%
Revenue/emp, $m 0.42 0.41 0.44 0.51 0.26 0.38 0.35 0.34 0.35 0.36 — (1.6%)
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026

Avient Corporation vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
BCPC Balchem Corporation $5.7B 33.8× 31.0× +8.63% (above 0%: growing) +17.74% (above 0%: growing) +14.42% (above 0%: growing) 36.37% 21.48% Compare
SXT Sensient Technologies Corporation $5.1B 30.0× 28.0× +10.61% (above 0%: growing) +31.03% (above 0%: growing) −90.87% (below 0%: shrinking) 36.19% 15.89% Compare
PRM Perimeter Solutions, SA $4.6B 102× 27.1× +23.59% (above 0%: growing) n/m −22.31% (below 0%: shrinking) 61.14% 106.82% Compare
AVNT Avient Corporation $4.2B 23.1× 17.6× +10.50% (above 0%: growing) +31.78% (above 0%: growing) +101.69% (above 0%: growing) 30.50% 9.27%
CLMT Calumet, Inc. $3.8B — (loss-making) — (loss-making) +40.77% (above 0%: growing) n/m +450.65% (above 0%: growing) 1.27% (2.77%) Compare
CBT Cabot Corporation $3.8B 17.4× 17.2× +12.24% (above 0%: growing) +79.43% (above 0%: growing) −51.65% (below 0%: shrinking) 20.22% 11.99% Compare
ASH Ashland Inc. $3.5B 67.1× 39.4× +4.40% (above 0%: growing) n/m +400.00% (above 0%: growing) 35.94% 5.82% Compare
HWKN Hawkins, Inc. $3.2B 36.6× 36.3× +11.90% (above 0%: growing) +23.06% (above 0%: growing) +1.32% (above 0%: growing) 24.41% 13.35% Compare
WDFC WD-40 Company $3.0B 37.0× 32.3× +8.14% (above 0%: growing) −31.85% (below 0%: shrinking) +63.49% (above 0%: growing) 52.78% 10.78% Compare
Median of peers $3.8B 36.6× 31.0× +11.26% +23.06% +7.87% 36.07% 12.67%

All 61 Specialty Chemicals stocks →

Pay and ownership Proxy statement filed 27 March 2026

Ownership

Directors and executive officers, together less than 1%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Avient Corporation (AVNT) Latest News

5 Nov

Impact 3 · · Simply Wall St.
Impact 3 · · MarketBeat

4 Nov

Impact 3 · · GuruFocus.com
Impact 3 · · The Motley Fool transcript
Impact 3 · · Moby
Impact 3 · · Associated Press
Impact 3 · · PR Newswire

28 Oct

Impact 3 · · Zacks
Impact 3 · · Zacks
Impact 3 · · Simply Wall St.

26 Oct

Impact 3 · · Zacks

17 Oct

Impact 4 ·
Impact 3 · · Simply Wall St.

16 Oct

Impact 3 · · Zacks
Impact 3 · · Zacks

12 Oct

Impact 3 · · Zacks
Impact 3 · · Zacks

9 Oct

Impact 4 · · Investing.com
Impact 4 · · PR Newswire
Impact 3 · · TIKR

8 Oct

Impact 3 · · Simply Wall St.

7 Oct

Impact 4 · · Zacks

6 Oct

Impact 3 · · PR Newswire

2 Oct

Impact 4 · · Zacks

1 Oct

Impact 3 · · Simply Wall St.

30 Sep

Impact 3 · · Zacks

25 Sep

Impact 3 · · Zacks

22 Sep

Impact 3 ·

14 Sep

Impact 3 ·

5 Sep

Impact 3 ·

AVNT metrics, ten years each

stockrow.com/AVNT · Data as of Nov 5, 2026 · For information only; not investment advice. · © 2026 stockrow.com